Duodenal--Jejunal Bypass Sleeve: A Totally Endoscopic Device for the Treatment of Morbid Obesity

December 2007
Surgical Innovation;Dec2007, Vol. 14 Issue 4, p275
Academic Journal
No abstract available.


Related Articles

  • Is Systemic Inflammation Not Involved in Endoscopic Duodenal-Jejunal Bypass Liner-Induced Diabetes Remission? Wu, Cheng-I; Lee, Wei-Jei; Chen, Chih-Yen // Obesity Surgery;Nov2014, Vol. 24 Issue 11, p2001 

    A letter to the editors is presented "Six months of treatment with the endoscopic duodenal-jejunal bypass liner does not lead to decreased systemic inflammation in obese patients with type 2 diabetes," by C. de Jonge and colleagues in the 2014 issue.

  • Endo Barrier trial to begin in US. Costa, Samantha; Kaplan, Lee M. // Endocrine Today;Mar2013, Vol. 11 Issue 3, p23 

    The article reports on the Endo Barrier endoscopic, drug-free device is believed to create a physical barrier when anchored in the duodenum to create a duodenal-jejunal bypass.

  • In obesity with type 2 diabetes, duodenal-jejunal bypass liners improved weight loss and HbA1c during treatment. Cheskin, Lawrence J.; Mullin, Gerard E. // Annals of Internal Medicine;2/17/2015, Vol. 162 Issue 4, pJC9 

    The article discusses the study "The effect of the endoscopic duodenal-jejunal bypass liner on obesity and type 2 diabetes mellitus, a multicenter randomized controlled trial" by P. Koehestanie and colleagues and published in a 2014 issue of the periodical "Annals of Surgery". Topics discussed...

  • NICE says trial coverage for bypass sleeve. McCARTY, MARK // Medical Device Daily;12/4/2013, Vol. 17 Issue 233, p9 

    The article focuses on the opinion given by the British National Institute for Health and Care Excellence (NICE) on the implantation of duodenal-jejunal bypass sleeve (DJBS) for management of obesity. Topics discussed include the call for clinicians to register their patients in the National...

  • The Duodenal-Jejunal Bypass Sleeve (EndoBarrier Gastrointestinal Liner) for Weight Loss and Treatment of Type II Diabetes. Patel, Shaneel; Mason, John; Hakim, Nadey // Indian Journal of Surgery;Aug2012, Vol. 74 Issue 4, p275 

    The author discusses the use of the duodenal-jejunal bypass sleeve technology to be used as a method of inducing weight loss especially in the case of obese patients with type 2 diabetes. Levels of excess weight loss are encouraging and suggest that the device may be useful in effectively...

  • The feasibility of delivering a duodenal-jejunal bypass liner (endobarrier) endoscopically with patients under conscious sedation. Koehestanie, Parviez; Betzel, Bark; Dogan, Kemal; Berends, Frits; Janssen, Ignace; Aarts, Edo; Groenen, Marcel; Wahab, Peter // Surgical Endoscopy;Jan2014, Vol. 28 Issue 1, p325 

    Background: The endoscopically placed duodenal-jejunal bypass liner (DJBL) or EndoBarrier gastrointestinal liner has been designed for the treatment of type 2 diabetes mellitus and simultaneous achievement of weight loss by obese patients. This study was performed to determine the safety,...

  • The Duodenal-Jejunal Bypass Liner for the Treatment of Type 2 Diabetes Mellitus and/or Obesity: a Systematic Review. Zechmeister-Koss, Ingrid; Huić, Mirjana; Fischer, Stefan // Obesity Surgery;Feb2014, Vol. 24 Issue 2, p310 

    This systematic literature review applies the GRADE approach to evaluate the efficacy and safety of the duodenal-jejunal bypass liner (DJBL) for the treatment of (a) patients with obesity ≥ grade II (with comorbidities) and (b) patients with type 2 diabetes mellitus + obesity ≥ grade...

  • Duodenal-jejunal bypass liner improved glycemic control, weight. Altersitz, Katrina; Costa, Samantha; Foster, Melissa // Endocrine Today;Oct2013, Vol. 11 Issue 10, p42 

    The article discusses the results of a study which showed the safety and effectiveness of duodenal-jejunal bypass liner device for the management of obese patients with type 2 diabetes, referencing a research by Julian Teare of the Imperial College of Healthcare National Health Service (NHS) Trust.

  • An Update on Less Invasive and Endoscopic Techniques Mimicking the Effect of Bariatric Surgery. Verdam, Froukje J.; Schouten, Ruben; Greve, Jan Willem; Koek, Ger H.; Bouvy, Nicole D. // Journal of Obesity;2012, Vol. 2012, p1 

    Obesity (BMI 30-35 kg/m2) and its associated disorders such as type 2 diabetes, nonalcoholic fatty liver disease, and cardiovascular disease have reached pandemic proportions worldwide. For the morbidly obese population (BMI 35-50 kg/m2), bariatric surgery has proven to be the most effective...

  • Chronic in-vivo experience with an endoscopically delivered and retrieved duodenal-jejunal bypass sleeve in a porcine model. Tarnoff, M.; Shikora, S.; Lembo, A.; Gersin, K. // Surgical Endoscopy;Apr2008, Vol. 22 Issue 4, p1023 

    The role of duodenal bypass as an underlying mechanism of action in gastric bypass surgery has received considerable attention. We report the initial feasibility study of a totally endoscopically delivered and retrieved duodenal–jejunal bypass sleeve in a chronic porcine model. The...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics